At this time, posts about Intronbio are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 40,000 shares today. Intronbio is known as a manufacturer of biopharmaceuticals and alternatives to antibiotics for animals.


As of 12:30 PM on the 29th, Intronbio's stock price is 26,600 KRW, up 15.65% from the previous day, with a trading volume of 4,250,024 shares, which is 224.05% of the 5-day average trading volume.


In addition to Intronbio, posts by investors are also rapidly increasing for Samgi (122350), KT (030200), and MP Group (065150).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing